Recently, we collected multiple clear cell sarcoma cell lines and we are in the process of sequencing these cells so that we can learn more
As the newest lab member at cc-TDI, I began research on clear cell sarcoma in late November of 2018. My immediate goal is to collect
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
Since pediatric cancers are (fortunately!) fairly rare, it’s ever more important for us to do our work with the spirit of collaboration. Thanks to the
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
My name is Dr. Jody Hooper, MD, and I am the Director of the Legacy Gift Rapid Autopsy Program and Director of Autopsy at Johns
What a week! Our 2018 Nanocourse wrapped up last week, and what an amazing week it was. For those of you who are curious, the
Recently, we collected multiple clear cell sarcoma cell lines and we are in the process of sequencing these cells so that we can learn more
As the newest lab member at cc-TDI, I began research on clear cell sarcoma in late November of 2018. My immediate goal is to collect
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
Since pediatric cancers are (fortunately!) fairly rare, it’s ever more important for us to do our work with the spirit of collaboration. Thanks to the
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
My name is Dr. Jody Hooper, MD, and I am the Director of the Legacy Gift Rapid Autopsy Program and Director of Autopsy at Johns
What a week! Our 2018 Nanocourse wrapped up last week, and what an amazing week it was. For those of you who are curious, the
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2019 – Children’s Cancer Therapy Development Institute